§ 866.3290. Gonococcal antibody test (GAT).
124 words·~1 min read·
/us/cfr/t21/s§ 866.3290·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
(a)Identification. A gonococcal antibody test
(GAT)is an in vitro device that consists of the reagents intended to identify by immunochemical techniques, such as latex agglutination, indirect fluorescent antibody, or radioimmunoassay, antibodies to Neisseria gonorrhoeae in sera of asymptomatic females at low risk of infection. Identification of antibodies with this device may indicate past or present infection of the patient with Neisseria gonorrhoeae.
(b)Classification. Class III (premarket approval) (transitional device).
(c)Date PMA or notice of completion of a PDP is required. As of May 28, 1976, an approval under section 515 of the act is required before this device may be commercially distributed. See § 866.3. [47 FR 50823, Nov. 9, 1982, as amended at 52 FR 17734, May 11, 1987]